WTHI |
Amylin Seeks FDA Approval on Extended Byetta Treatment
Wall Street Journal – David Benoit The company submitted exenatide, an injection treatment fortype 2 diabetes, after it showed in late March it had the ability to control blood sugar better than current tablet forms ofdiabetesdrugs. The treatment, which is co-developed with Eli Lilly… Exenatide Once Weekly New Drug Application Submitted to FDA for…PR Newswire (press release) Lilly, Amylin, Alkermes file for FDA drug approvalMarketWatch Amylin, Lilly Seek FDA Approval For First-Ever Once-Weekly…Trading Markets (press release) San Diego Business Journal –MSN Money all 199 news articles |
Discussion
Comments are disallowed for this post.
Comments are closed.